v3.25.2
REVERSE RECAPITALIZATION - Narrative (Details)
12 Months Ended
Oct. 02, 2024
USD ($)
Jul. 12, 2024
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
May 06, 2025
$ / shares
Dec. 31, 2023
$ / shares
shares
Business Acquisition [Line Items]          
Shares authorized   110,000,000      
Common stock, stock authorized (in shares)   100,000,000 100,000,000   100,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Preferred shares, shares authorized (in shares)   10,000,000 10,000,000    
Preferred shares, par value (in dollars per share) | $ / shares   $ 0.0001      
Preferred stock, convertible, conversion ratio   1      
Shares converted upon business combination   2,427,791      
Conversion of convertible debt and accrued interest | $   $ 2,250,000 $ 3,779,223    
Purchase price (in dollars per share) | $ / shares   $ 7      
Conversion of convertible debt and accrued interest (in shares)   321,428      
Exchange ratio   3.3214%      
Public warrants expiration term   30 days      
Warrants expiration term   5 years      
Shares redeemed   3,665,639 3,665,639    
Rights issued to shareholders     920,000    
Shares purchased by investor     3,248,466    
Negative equity recapitalization | $   $ 2,704,909      
Additional paid in capital | $ $ 600,000   $ 3,960,397    
Monterey Capital Acquisition Corporation          
Business Acquisition [Line Items]          
Redemption of class a common stock | $   $ 41,652,720      
Rights issued to shareholders   920,000      
Rights conversion ratio   0.1      
Shares purchased by investor   3,248,466      
Additional paid in capital | $   $ 3,968,063